27Serious

Andreas Alm

Andreas Alm

Ask VT AI

View News Summary

Generac's Q3 earnings miss and reduced 2025 sales and margin guidance send shares tumbling, despite long-term growth drivers remaining intact.
Smurfit WestRock cuts full-year EBITDA forecast, citing weak North American demand and additional economic downtime in U.S. factories.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Latest News

Yankuba Minteh Brighton

100% left coverage1 source

Yankuba Minteh Brighton

100% left coverage1 source

Yankuba Minteh Brighton

Yankuba Minteh Brighton

Ask VT AI

View News Summary

Generac's Q3 earnings miss and reduced 2025 sales and margin guidance send shares tumbling, despite long-term growth drivers remaining intact.
Smurfit WestRock cuts full-year EBITDA forecast, citing weak North American demand and additional economic downtime in U.S. factories.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Andreas Alm